Evidence map›Paper›PMID 22277551›Full record

ArticleThe American journal of clinical nutrition2012

Dietary intake of PUFAs and colorectal polyp risk.

Harvey J Murff, Martha J Shrubsole, Qiuyin Cai, Walter E Smalley, Qi Dai, Ginger L Milne, Reid M Ness, Wei Zheng

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The American journal of clinical nutrition, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00625066 (Tennessee Colorectal Polyp Study), which is not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00625066 completednot on this map

Tennessee Colorectal Polyp Study

TypeobservationalSponsorVanderbilt UniversityRan2003 to 2025Enrolled8,108ConditionsColorectal Cancer, Precancerous ConditionArmsbiologic sample preservation procedure, cytology specimen collection procedure, medical chart review, questionnaire administration, survey administration
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Assessing the safety of transarterial locoregional delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat liver.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2021
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Harvey J MurffDivision of General Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN 37203, USA. harvey.j.murff@vanderbilt.edu
Martha J Shrubsole
Qiuyin Cai
Walter E Smalley
Qi Dai
Ginger L Milne
Reid M Ness
Wei Zheng
Vanderbilt University · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Understanding and Controlling p120 Dysfunction in CRCP50CA095103 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J. · 2002 to 2017
$33.6M
Tumor Markers and Recurrent Adenomas: A Follow-up StudyR01CA097386 · NCI · VANDERBILT UNIVERSITY · PI ZHENG, WEI · 2002 to 2006
$3.6M
Fatty acid desaturase activity, fish oil and colorectal cancer chemopreventionR01CA160938 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MURFF, HARVEY J. · 2011 to 2014
$1.3M
Long-Chain Fatty Acids, Oxidative Stress and Colorectal Neoplasm RiskR01CA143288 · NCI · VANDERBILT UNIVERSITY · PI MURFF, HARVEY J. · 2010 to 2013
$1.0M
Mechanisms and Management of Familial Colon CancerK07CA114029 · NCI · VANDERBILT UNIVERSITY · PI MURFF, HARVEY J. · 2006 to 2010
$651k
NCI NIH HHS K07 CA114029NCI NIH HHS K07CA114029NCI NIH HHS P30 CA068485NCI NIH HHS P30CA68485NCI NIH HHS P50 CA095103NCI NIH HHS P50CA 95103NCI NIH HHS R01 CA097386NCI NIH HHS R01 CA143288NCI NIH HHS R01CA143288NCI NIH HHS R01 CA160938NCI NIH HHS R01CA97386
6 · The paper itself

Abstract

backgroundMarine-derived n-3 (omega-3) PUFAs may reduce risk of developing colorectal cancer; however, few studies have investigated the association of n-3 PUFA intakes on colorectal polyp risk.

objectiveThe objective of this study was to examine the associations of dietary PUFA intake on risk of colorectal adenomatous and hyperplastic polyps.

designThis was a colonoscopy-based case-control study that included 3166 polyp-free control subjects, 1597 adenomatous polyp cases, and 544 hyperplastic polyp cases. Dietary PUFA intake was calculated from food-frequency questionnaires and tested for association by using unconditional logistic regression. The urinary prostaglandin E(2) metabolite, which is a biomarker of prostaglandin E(2) production, was measured in 896 participants by using liquid chromatography and tandem mass spectrometry.

resultsn-6 PUFAs were not associated with adenomatous or hyperplastic polyps in either men or women. Marine-derived n-3 PUFAs were associated with reduced risk of colorectal adenomas in women only, with an adjusted OR of 0.67 (95% CI: 0.47, 0.97) for the highest quintile of intake compared with the lowest quintile of intake (P-trend = 0.01). Dietary intake of α-linolenic acid was associated with an increased risk of hyperplastic polyps in men (P-trend = 0.03), which was not seen in women. In women, but not in men, dietary intake of marine-derived n-3 PUFAs was negatively correlated with urinary prostaglandin E(2) production (r = -0.18; P = 0.002).

conclusionHigher intakes of marine-derived n-3 PUFAs are associated with lower risk of adenomatous polyps in women, and the association may be mediated in part through a reduction in the production of prostaglandin E(2). This trial was registered at clinicaltrials.gov as NCT00625066.

Indexed as

Dietary SupplementsAdenomatous PolypsAdultAgedBiomarkersCase-Control StudiesColonic PolypsColonoscopyColorectal NeoplasmsDinoprostoneFatty Acids, Omega-3FemaleHumansMaleMiddle AgedRisk FactorsBiomarkersDinoprostoneFatty Acids, Omega-3

Identifiers

PMID22277551
PMCPMC3278245
OpenAlexW2128051835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.